BioStone Animal Health Joins International Partnership to Develop Nipah Virus Vaccine and Companion Diagnostic Test for Pigs

News

BioStone will develop a DIVA ELISA to support vaccine evaluation and disease surveillance. Dallas–Fort Worth, TX — October 15, 2026 — BioStone Animal Health LLC is pleased to announce its participation in Duo-ProTectz, a three-year international research project led by The Pirbright Institute in the United Kingdom. The project aims to develop a bivalent vaccine…

BioStone Animal Health Advances Nipah Virus Antibody Surveillance with Multi-Species iELISA

News

DALLAS-FORT WORTH, TX — January 29, 2026  — In response to the recent Nipah virus (NiV) outbreak reported in India, BioStone Animal Health has launched a multi-species indirect ELISA (iELISA) Test kit for Nipah virus antibody detection (Cat. 10101), designed to support surveillance, biosecurity, and outbreak preparedness. Nipah virus is a highly pathogenic zoonotic virus with recurrent outbreaks…